Presentation TCT 2025 TCT 187: Three-Year Follow-up of the First Everolimus-Coated Balloon for Patients with In-Stent Restenosis Presenter: Fernando Alfonso October 28, 2025
Presentation TCT 2025 Everolimus-Coated Balloon Intervention for Patients with In-Stent Restenosis: 3-Year Clinical Results Presenter: Fernando Alfonso October 26, 2025
Presentation TCT 2025 Abluminus Sirolimus DES+ vs. Everolimus-Eluting Stents in Patients with Diabetes Mellitus: Final 2-Year Results of the ABILITY Global Study Presenter: Alexandre Abizaid October 25, 2025
Presentation TCT 2024 TCT 427: Comparison of Clinical Outcomes Between Second Generation Zotarolimus- Versus Everolimus-Eluting Stents up to 10-Year Follow-up Presenter: Woo Jin Ahn October 29, 2024
Presentation TCT 2024 TCT 418: Efficacy and Safety of the Bioabsorbable Polymer Everolimus-Eluting Stent in Routine Clinical Practice: Data From the IRIS-DES Registry Presenter: Kyeong-Won Seo October 28, 2024
Presentation TCT 2024 TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study Presenter: Richard Pin October 27, 2024
Presentation EuroPCR 2024 Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study Presenter: Alexandre Abizaid May 14, 2024
Presentation TCT 2023 TCT 80: The Everolimus Eluting Synergy MegatronTM Drug-eluting Stent Platform for Aorto-ostial and Proximal Coronary Disease – Early Outcomes from the European Synergy MegatronTM Implanters' Registry Presenter: Matthew Li Kam Wa October 26, 2023
Presentation TCT 2023 TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials Presenter: Usman Naseer October 25, 2023
Presentation TCT 2023 Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial Presenter: Juan Iglesias October 25, 2023
Presentation TCT 2023 Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial Presenter: Giovanni Esposito October 25, 2023
Presentation TCT 2023 Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis Presenter: Manel Sabate October 24, 2023
Presentation TCT 2022 Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial Presenter: Jung-Min Ahn September 19, 2022
Presentation TCT 2022 TCT 159: Percutaneous Coronary Intervention of Large Coronary Vessels with the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 4.5/5.0 mm Stent: Primary Outcomes of the EVOLVE Large Vessel Study Presenter: Elissa Altin September 19, 2022
Presentation TCT 2022 TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption Presenter: Gabriele Pesarini September 17, 2022
Presentation TCT 2021 TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes Presenter: Pasi Karjalainen November 06, 2021
Presentation TCT 2020 TCT ID 7: Everolimus-Eluting Stent vs Bare-Metal Stent in ST-Segment Elevation Myocardial Infarction – 10-Year Follow-up of the Multicentre Randomized Controlled Examination Trial Presenter: Salvatore Brugaletta October 15, 2020
Presentation TCT 2020 TCT 262: Percutaneous Coronary Intervention of Long Coronary Lesions With the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 48 mm Stent: Primary Outcomes of the EVOLVE 48 Study Presenter: Dimitri Karmpaliotis October 14, 2020
Presentation TCT 2020 TCT 269: A First-in-Human Study of the Second-Generation, Thin-Strut, Everolimus-Eluting Bioresorbable Scaffold: Final IVUS and OCT Results From the FAST Clinical Trial Presenter: Takeshi Nishi October 14, 2020
Presentation TCT 2020 TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry Presenter: Sridhar Kasturi, MD October 14, 2020